Valuation: Square Pharmaceuticals PLC.

Market Cap 194B 1.58B 1.4B 1.31B 1.19B 2.25B 151B 2.27B 15.81B 6.13B 77.42B 5.92B 5.79B 248B P/E 2026 *
7.38x
P/E 2027 * 6.57x
Enterprise Value 194B 1.58B 1.4B 1.31B 1.19B 2.25B 151B 2.27B 15.81B 6.13B 77.42B 5.92B 5.79B 248B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 2.04x
Free-Float
55.9%
Yield 2026 *
-
Yield 2027 * -
1 day+0.14%
1 week+0.32%
Current month+0.14%
1 month+0.32%
3 months-1.49%
6 months+2.63%
Current year+9.92%
1 week 216.7
Extreme 216.7
218.8
1 month 210
Extreme 210
218.8
Current year 198.1
Extreme 198.1
236
1 year 198
Extreme 198
236
3 years 197.2
Extreme 197.2
249.8
5 years 197.2
Extreme 197.2
249.8
10 years 149.05
Extreme 149.047619
278.67
Manager TitleAgeSince
Chief Executive Officer - 31/12/1994
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman - 31/12/2011
Director/Board Member - 31/12/1979
Director/Board Member - 31/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%+0.32%+1.53%+4.05% 1.58B
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -0.67%-3.01%+23.62%+53.42% 369.88B
Weighted average by Cap. -0.60%-3.32%+29.06%+71.12%

Financials

2026 *2027 *
Net sales 85.11B 693M 616M 575M 524M 988M 66.61B 997M 6.95B 2.69B 34.05B 2.6B 2.55B 109B 94.79B 772M 686M 640M 583M 1.1B 74.19B 1.11B 7.74B 3B 37.92B 2.9B 2.83B 122B
Net income 26.6B 217M 192M 180M 164M 309M 20.82B 312M 2.17B 842M 10.64B 813M 795M 34.16B 29.57B 241M 214M 200M 182M 343M 23.14B 346M 2.42B 936M 11.83B 904M 884M 37.97B
Net Debt - -
Logo Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.
Employees
15,937
Date Price Change Volume
01/10/26 BDT 218.30 +0.14% 278,295
30/09/26 BDT 218.00 +0.28% 261,124
29/09/26 BDT 217.40 -0.14% 176,391
28/09/26 BDT 217.70 +0.14% 242,455
27/09/26 BDT 217.40 -0.09% 360,044
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
218.30BDT
Average target price
352.20BDT
Spread / Average Target
+61.34%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SQURPHARMA Stock